Method for purifying nanoparticles, nanoparticle composition, and method for producing nanoparticle composition
The method of using a low dielectric solvent and associative ligands stabilizes the α phase in quantum dots, overcoming the challenges of high-temperature synthesis and instability, thereby improving their luminescence and power generation characteristics.
Patent Information
- Application Number
- PCT/JP2024/017359
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-19
- Filing Date
- 2024-05-10
- Publication Date
- 2024-11-28
AI Technical Summary
Existing methods for producing quantum dots with a perovskite crystal structure face challenges in achieving the α phase, which has optimal luminescence and power generation characteristics, due to high temperature requirements and instability over time.
A method involving the use of a solvent with a low dielectric constant and an associative ligand with a polar group that self-associates, allowing for the selective stabilization of the α phase in nanoparticles, enabling their production and maintenance at lower temperatures.
This approach allows for the production and long-term maintenance of α-phase quantum dots, enhancing their luminescence and power generation properties while reducing the need for high-temperature synthesis.
Smart Images

Figure JP2024017359_28112024_PF_FP_ABST
Abstract
Description
Nanoparticle purification method, nanoparticle composition, and method for producing nanoparticle composition
[0001] The present disclosure relates to methods for purifying nanoparticles, nanoparticle compositions, and methods for making nanoparticle compositions.
[0002] Quantum dots with a perovskite crystal structure have a narrow full width at half maximum in their spectral sensitivity characteristics and exhibit high color purity, making them well-known for their application in organic electroluminescence (EL) materials, quantum dot light-emitting materials, and solar cell materials. Furthermore, because the absorption and emission wavelengths can be controlled by the halogen composition, they have the advantage of easily providing materials that respond to light over a wide wavelength range.
[0003] Quantum dots with a perovskite crystal structure are known to take on a variety of crystal phases depending on the synthesis and storage conditions (Phys. Rev. Materials 3, 113605). Their light-emitting and power-generating properties are significantly affected by the type of crystal phase. The α phase offers the best properties, but because the α phase is stable at high temperatures, it is difficult to selectively produce it using conventional synthesis methods.
[0004] Angew. Chem. Int. Ed. 2018, 57, 9083-9087, quantum dots having an α phase are obtained by synthesizing quantum dots under a high-temperature condition of 260°C while using oleylamine hydroiodide.
[0005] Phys. Rev. Materials 3, 113605Angew. Chem. Int. Ed. 2018, 57, 9083-9087
[0006] However, the synthesis method described in Angew. Chem. Int. Ed. 2018, 57, 9083-9087 requires a high temperature condition of 260° C., which limits its industrial application. In addition, the quantum dots obtained by the synthesis method described in Angew. Chem. Int. Ed. 2018, 57, 9083-9087 have the problem that the crystalline phase gradually changes from the α phase over time.
[0007] The present invention has been made in view of the above-mentioned problems, and aims to provide a method for purifying nanoparticles that can obtain the α-phase at lower temperatures, and a nanoparticle composition that can maintain the α-phase over time.
[0008] A method for purifying nanoparticles according to an embodiment of the present invention includes the steps of: preparing nanoparticles that contain a perovskite-type crystal structure as an allotrope and exhibit multiple crystal structures; preparing a ligand liquid containing a solvent that exhibits a relative dielectric constant of a predetermined value or less and an associative ligand that has a main chain containing multiple carbons and a polar group that is more polar than the main chain and that self-associates in the solvent; and contacting the nanoparticles with the ligand liquid to prepare a nanoparticle dispersion, wherein the step of adjusting the nanoparticle dispersion includes a step of selectively increasing the proportion of the content of a predetermined crystal structure among the multiple crystal structures.
[0009] Furthermore, a method for producing a nanoparticle composition according to an embodiment of the present invention includes the steps of: preparing nanoparticles that contain a perovskite-type crystal structure as an allotrope and exhibit a plurality of crystal structures; preparing a ligand liquid containing a solvent that exhibits a relative dielectric constant of a predetermined value or less and an associative ligand that has a main chain containing a plurality of carbons and a polar group that is more polar than the main chain and that self-associates in the solvent; and bringing the nanoparticles into contact with the ligand liquid to prepare a nanoparticle dispersion, wherein the step of adjusting the nanoparticle dispersion includes a step of selectively increasing the proportion of the content of a predetermined crystal structure among the plurality of crystal structures.
[0010] Furthermore, a nanoparticle composition according to an embodiment of the present invention comprises nanoparticles having a perovskite-type crystal structure as an allotrope, and associative ligands having a main chain containing a plurality of carbon atoms and a polar group having a polarity greater than that of the main chain, wherein at least a portion of the associative ligands are coordinated to the nanoparticles via the polar group so as to change the crystal structure of the nanoparticles.
[0011] Furthermore, a nanoparticle composition according to an embodiment of the present invention comprises: a solvent exhibiting a relative dielectric constant of a predetermined value or less; nanoparticles having a perovskite-type crystal structure as an allotrope; and a plurality of ligands having a main chain containing a plurality of carbon atoms and a polar group having a polarity greater than that of the main chain, wherein the plurality of ligands comprise a first component that forms a reverse micelle-like structure in the solvent; and a second component that coordinates to the particle surface of the nanoparticles.
[0012] According to the present invention, a method for purifying nanoparticles that can obtain the α-phase at lower temperatures can be provided, and a nanoparticle composition that can maintain the α-phase over time can be provided.
[0013] FIG. 1 is a process chart of a method for producing a nanoparticle composition according to a first embodiment. FIG. 2 is a process chart of a method for purifying nanoparticles according to a first embodiment. FIG. 3 is a diagram showing a schematic configuration of nanoparticles P and ligand liquid Q (60-1 to 60-4) according to a first embodiment. FIG. 4 is a diagram showing a schematic configuration of nanoparticles P and ligand liquid Q (60-1 to 60-4) according to a first embodiment. FIG. 5 is a diagram showing a schematic configuration of nanoparticles P and ligand liquid Q (60-1 to 60-4) according to a first embodiment. FIG. 6 is a diagram showing a schematic configuration of nanoparticles P and ligand liquid Q (60-1 to 60-4) according to a first embodiment. FIG. 7 is a diagram showing a schematic structure of a nanoparticle composition according to a second embodiment. FIG. 8 is a diagram showing a schematic structure of a nanoparticle composition according to a second embodiment. FIG. 9 is a diagram showing a schematic structure of a nanoparticle composition according to a third embodiment. FIG. 10 is a diagram showing a schematic structure of a nanoparticle composition according to a third embodiment. FIG. 11 is a diagram showing a schematic structure of a nanoparticle composition according to a third embodiment. FIG. 12 is a diagram showing a schematic structure of a wavelength conversion layer and a display element containing a nanoparticle composition according to a fourth embodiment.
[0014] Preferred embodiments of the present invention will be described in detail below with reference to the accompanying drawings. The dimensions, materials, shapes, relative positions, and other details of the components described in these embodiments are not intended to limit the scope of the present invention.
[0015] First Embodiment A method and composition for producing a nanoparticle composition according to a first embodiment, as well as a method for purifying nanoparticles, will be described with reference to FIGS. 1A, 1B, and 2A to 2D.
[0016] As shown in FIG. 1A, the method 1000 for producing a nanoparticle composition according to the first embodiment includes at least steps S103, S105, S107, and S109 between a start step S101 and a finish step S111.
[0017] (S103) Step S103 is a step of preparing nanoparticles A that contain a perovskite-type crystal structure as an allotrope and exhibit a plurality of crystal structures.
[0018] (S105) Step S105 is a step of preparing a ligand solution B containing a solvent 10 exhibiting a relative dielectric constant of a predetermined value or less, and an associative ligand 60 having a main chain 40 containing a plurality of carbon atoms and a polar group 50 that is more polar than the main chain 40, and that self-associates in the solvent 10.
[0019] (S107, S109) Step S107 is a step of preparing nanoparticle dispersion C by contacting nanoparticles P with ligand liquid Q, and includes step S109 of selectively increasing the ratio of the content of a specific crystal structure among multiple crystal structures.
[0020] The method 1000 for producing a nanoparticle composition according to this embodiment includes a step S109 for selectively increasing the content ratio of a specific crystal structure among multiple crystal structures corresponding to nanoparticles P, and therefore may be referred to as a method 1000 for purifying nanoparticles.
[0021] The present inventors believe that the mechanism by which the content ratio of a predetermined crystal structure is selectively increased in the nanoparticle composition manufacturing method 1000 is as follows.
[0022] First, as a premise, nanoparticles P, which contain a perovskite-type crystal structure as an allotrope, are unstable with respect to polar substances, and therefore, when dispersed and supported in a solvent, they must be dispersed in a solvent (low-polarity solvent) that exhibits a relative dielectric constant below a predetermined value.
[0023] Next, a case will be considered in which, with the intention of protecting nanoparticles P that contain a perovskite-type crystal structure as an allotrope, ligands having polar groups are coordinated to the particle surfaces of nanoparticles P.
[0024] Ligands with polar groups have low affinity for low-polarity solvents, so they cannot be applied in large quantities to nanoparticles P. On the other hand, associative ligands 60 exhibit self-association in relation to the solvent, the apparent polarity is reduced by the association of polar groups 50 with each other, allowing polar moieties to exist at high concentrations even in low-polarity solvents (ligand liquid Q). In this specification, the self-association of a ligand refers to the property of forming a reverse micelle-like structure in which nonpolar groups face the solvent side, due to at least one of the association of a single ligand with itself and the association of multiple related ligands with each other.
[0025] When the ligand liquid Q is brought into contact with the nanoparticles P, a component 60-a is generated in the solvent 10, where at least a portion of the self-associated associative ligands 60 is dissociated, and a component 60-b that maintains the self-association is generated. The dissociated ligands 60-a of the associative ligands 60 are thought to coordinate to the particle surface of the nanoparticles P. In other words, at least a portion of the nanoparticles P is protected so as to be incorporated into the associated portion of the associative ligands 60. The multiple polar groups 50 possessed by the associative ligands 60 are coordinated to the particle surface of the nanoparticles P all at once. The inventors presume that this sudden coordination serves as the driving force to induce a change to the α phase, which is stable at high temperatures.
[0026] (Self-association) In this embodiment, self-association refers to the association of at least some of the polar groups 50 with each other due to electrostatic interaction in a solvent 10 exhibiting a relative dielectric constant of a predetermined value or less. The polar groups 50 do not necessarily have to interact directly with each other; a small amount of polar substance such as water may be present between them. Furthermore, as shown in FIG. 2B , the self-association may be an intermolecular association (60-1) or an intramolecular association (60-2). Furthermore, a case in which different types of polar groups associate with each other due to electrostatic interaction and form an inverted micelle-like structure in a common solvent 10 is also considered to be self-associated.
[0027] (Nanoparticles) In this embodiment, the nanoparticles P are nanoparticles containing nanocrystals as allotropes having a perovskite crystal structure with A site (monovalent cation), B site (divalent cation), and X site (monovalent anion including halide anion) as constituent components. The perovskite crystal structure is a perovskite structure, ABX 3 Type crystal structure, ABX 3 This can be rephrased as a type structure. 2 B 1 B 2 X 6 The perovskite crystal structure also includes a double perovskite crystal structure represented by the following formula: In this specification, the nanoparticles P may be referred to as luminescent nanoparticles, luminescent nanocrystals, photoresponsive nanocrystals, or quantum dots.
[0028] The average particle size of the nanoparticles is preferably 1 nm or more and 30 nm or less, and more preferably 2 nm or more and 25 nm or less. If the average particle size is less than 1 nm, the stability may be insufficient. If the average particle size is more than 30 nm, the dispersibility in the medium may be insufficient.
[0029] [A Site of Perovskite Structure] A monovalent cation is used at the A site. The monovalent cation used at the A site is an ammonium cation (NH 4 + ), and alkylammonium cations having 6 or less carbon atoms, formamidinium cations (HC(NH 2 ) 2 + ), guanidinium cation (C(NH 2 ) 3 + cations of nitrogen-containing organic compounds such as imidazolium cation, pyridinium cation, and pyrrolidinium cation; and lithium cation (Li + ), sodium cation (Na + ), potassium cation (K + ), rubidium cation (Rb + ), and cesium cation (Cs + ) and other alkali metal cations.
[0030] These monovalent cations employed in the A site have a small ion diameter and are large enough to fit into the crystal lattice, allowing the perovskite compound to form a stable three-dimensional crystal.
[0031] Preferred examples of alkylammonium cations having 6 or less carbon atoms include methylammonium cations (CH 3 NH 3 + ), ethylammonium cation (C 2 H 5 NH 3 + ), propylammonium cation (C 3 H 7 NH 3 + ) etc.
[0032] From the viewpoint of obtaining high luminous efficiency, it is preferable to use at least one of methylammonium cation, formamidinium cation, and cesium cation as the A site, and from the viewpoint of suppressing color change, it is more preferable to use cesium cation as the A site. Two or more of these monovalent cations employed as the A site may be used in combination.
[0033] When the A site is a cesium cation, a raw material for synthesizing nanoparticles can be a cesium salt. Examples of such cesium salts include cesium chloride, cesium bromide, cesium iodide, cesium hydroxide, cesium carbonate, cesium hydrogen carbonate, cesium bicarbonate, cesium formate, cesium acetate, cesium propionate, cesium pivalate, and cesium oxalate. An appropriate cesium salt can be used from these candidate salts depending on the synthesis method.
[0034] When the A site is another alkali metal cation, a salt in which the cesium element of the above-mentioned cesium compound is replaced with another alkali metal cation element can be used as the raw material.
[0035] When the A site is a nitrogen-containing organic compound cation such as a methylammonium cation, a neutral compound other than a salt such as methylamine can be used as the raw material. Two or more of these raw materials may be used in combination.
[0036] [B Site of Perovskite Crystal Structure] Divalent cations including divalent transition metal cations or divalent typical metal cations are employed in the B site of the perovskite crystal structure.
[0037] The divalent transition metal cation is scandium cation (Sc 2+ ), titanium cation (Ti 2 +), vanadium cation (V 2+ ), chromium cation (Cr 2+ ), manganese cations (Mn 2+ ), iron cation (Fe 2+ ), cobalt cation (Co 2+ ), nickel cation (Ni 2+ ), copper cation (Cu 2+ ), palladium cation (Pd 2+ ), europium cation (Eu 2+ ), ytterbium cation (Yb 2+ ) will be adopted.
[0038] The divalent typical metal cation is the magnesium cation (Mg 2+ ), calcium cation (Ca 2+ ), strontium cation (Sr 2+ ), barium cation (Ba 2+ ), zinc cation (Zn 2+ ), cadmium cation (Cd 2+ ), germanium cation (Ge 2+ ), tin cations (Sn 2+ ), lead cation (Pb 2+ ) may be employed.
[0039] Among these divalent cations, divalent typical metal cations are preferred in terms of growing stable three-dimensional crystals, tin cations or lead cations are more preferred, and lead cations are particularly preferred in terms of obtaining high luminescence intensity. Two or more of these divalent cations may be used in combination, and the perovskite crystal structure may be a so-called double perovskite structure.
[0040] When the B site is a lead cation, examples of raw materials used in nanoparticle synthesis include lead compounds, and appropriate compounds can be used depending on the synthesis method. Examples of lead compounds that can be used include lead chloride, lead bromide, lead iodide, lead oxide, lead hydroxide, lead sulfide, lead carbonate, lead formate, lead acetate, lead 2-ethylhexanoate, lead oleate, lead stearate, lead naphthenate, lead citrate, lead maleate, and lead acetylacetonate. When the B site is another divalent metal cation, salts of the above-mentioned lead compounds in which the lead element is replaced with another divalent metal cation element can be used as raw materials. Two or more of these raw materials may be used in combination.
[0041] [X Site of Perovskite Crystal Structure] A monovalent anion including a halide anion is used as X in the perovskite crystal structure. As the halide anion, a fluoride anion (F - ), chloride anion (Cl - ), bromide anion (Br - ), iodide anion (I - Among these, chloride anions, bromide anions, and iodide anions are preferred because they form stable three-dimensional crystals and emit strong light in the visible light range. The emitted light color is blue when chloride anions are used, green when bromide anions are used, and red when iodide anions are used.
[0042] Two or more halide anions may be used in combination. In particular, when chloride anions, bromide anions, and iodide anions are used in combination, the emission wavelength of the nanoparticles can be set to a desired wavelength depending on the content ratio of the anion species. That is, in particular, when chloride anions, bromide anions, and iodide anions are used in combination, an emission spectrum that covers almost the entire range of visible light from blue to red can be obtained while maintaining a narrow full width at half maximum depending on the content ratio of the anion species, which is preferable.
[0043] The X site may contain a monovalent anion other than a halide anion. Such a monovalent anion other than a halide anion may be a cyanide anion (CN - ), thiocyanate anion (SCN - ), isothiocyanate anion (CNS - As raw materials for synthesizing nanoparticles, an appropriate one can be selected depending on the synthesis method from salts with counter cations at the A site and B site, such as cesium chloride and lead bromide, and salts with other cations.
[0044] The nanoparticles P in this embodiment can be produced by the following process: For example, a hot injection method is used in which raw material solutions are mixed at high temperature, and then rapidly cooled after the formation of fine particles to obtain a stable product, and a ligand-assisted reprecipitation method is used in which fine particles are obtained by reprecipitation utilizing the difference in miscibility of the product with the solvent.
[0045] Another manufacturing method that can be used is a room-temperature synthesis method in which a mixture of non-halogenated A-site and B-site raw materials, which do not contain any X-site components, is mixed with a separately prepared X-site raw material solution under mild conditions at about room temperature to obtain fine particles.Furthermore, this manufacturing method can be used in a mechanochemical method in which solid raw materials are reacted by mechanical mixing such as milling or ultrasonic treatment to obtain product fine particles, and in a in situ synthesis method in which a raw material solution is applied to a substrate and then crystals are grown directly to obtain a reaction product.
[0046] By allowing the coexistence of a ligand, which will be described later, during the production of the nanoparticles P, the ligand can be coordinated to the surface of the nanoparticles P, thereby stabilizing the dispersion.
[0047] (Solvent) As the solvent, a low-polarity solvent (low-dielectric-constant solvent) having a dielectric constant of a predetermined value or less can be used. The predetermined value is preferably 6.0 or less, more preferably 4.5 or less.
[0048] Specific examples of low-polarity solvents include aromatic hydrocarbons such as xylene (dielectric constant 2.3) and toluene (dielectric constant 2.4); hydrocarbons such as hexane (dielectric constant 1.9); alicyclic hydrocarbons such as cyclohexane (dielectric constant 2.0); esters such as ethyl acetate (dielectric constant 6.0) and butyl acetate (dielectric constant 5.0); alkyl halides such as chloroform (dielectric constant 4.9); and ethers such as diethyl ether (dielectric constant 4.3). If necessary, these solvents can be mixed and used. In this case, the weighted average of the dielectric constants of the respective solvents is used.
[0049] (Ligand) In this embodiment, the ligand 60 is preferably selected from at least one compound or ion selected from the group consisting of weak acids such as carboxylic acids, weak bases such as amines, and salts or ions thereof.
[0050] Examples of the acid include branched or straight-chain fatty acids having 1 to 30 carbon atoms. The alkyl chain may be saturated or unsaturated. Among these, from the viewpoints of solubility in solvents and stability, straight-chain fatty acids are preferred, and oleic acid is more preferred.
[0051] Examples of the base include branched or linear organic bases having 1 to 30 carbon atoms. The alkyl chain may be saturated or unsaturated. Among these, from the viewpoints of solubility in solvents and stability, linear organic bases are preferred, and oleylamine is more preferred.
[0052] The ligand 60 may be used alone or in combination of two or more kinds.
[0053] (Amount of Ligands Relative to Nanoparticles P) When the nanoparticles P are taken as 100, the amount of ligands is preferably 10 or more and 500 or less, more preferably 20 or more and 400 or less, and even more preferably 30 or more and 300 or less. If the amount of ligands is less than 10 or more than 300, the dispersion stability of the nanoparticles P may become insufficient.
[0054] (Associating Ligand) In this embodiment, the associating ligand 60 includes an associating ligand that has a main chain 40 containing multiple carbon atoms and a polar group 50 that is more polar than the main chain 40, and that self-associates in the solvent 10. The associating ligand 60 may be composed of a low molecular weight compound as shown in FIG. 2B, or may be composed of a high molecular weight compound as shown in FIG. 2C. The associating ligand 60 may also contain both a low molecular weight compound and a high molecular weight compound (not shown). As shown in FIG. 2C, the associating ligand may self-associate intramolecularly, or as shown in FIG. 2D, the associating ligand may self-associate intermolecularly. In FIG. 2B, the main chain 40 of the ligand 60 is shown as a straight chain, but the main chain 40 may also have a branched skeleton.
[0055] From the viewpoint of more effectively inducing a change to the α phase, it is preferable that the material is mainly composed of a polymer compound.
[0056] The main chain 40 of the low molecular weight compound may be a linear, branched, or cyclic alkyl group, a linear, branched, or cyclic heteroalkyl group, an aryl group, a heteroaryl group, an aralkyl group, or a heteroaralkyl group, some of which may further have a substituent.
[0057] The polar group 50 is composed of a strong acid such as sulfonic acid or phosphonic acid, a strong base such as a quaternary ammonium cation, or a zwitterionic group such as sulfobetaine, phosphobetaine, or carboxybetaine. The polar group 50 also includes a form selected from at least one compound or ion selected from the group consisting of the salts or ions that are the aforementioned constituent elements.
[0058] As the polymer compound, a copolymer (described later) obtained by polymerizing at least two types of monomers can be used.
[0059] (Amount of associative ligand relative to nanoparticle P) When nanoparticle P is taken as 100, the amount of ligand is preferably 1 or more and 1000 or less, more preferably 10 or more and 800 or less, and even more preferably 30 or more and 600 or less. If the amount of associative ligand is less than 10, the effect of forming a single phase may not be sufficiently obtained. If the amount of associative ligand is more than 600, it may not be possible to successfully form an association of the associative ligand in the solvent.
[0060] (Number of mmoles of polar groups per 1 g of nanoparticles P) The number of mmoles of polar groups per 1 g of nanoparticles P is preferably 0.01 to 10, preferably 0.03 to 8, and more preferably 0.1 to 6. When the number of mmoles of polar groups per 1 g of nanoparticles P is within the above range, coordination to the nanoparticles P proceeds rapidly, and the crystal phase tends to become a single phase. When it is less than 0.01, the crystal phase may not become a single phase sufficiently. When it is more than 10, associations may not be formed well in a low-polarity medium. The number of mmoles corresponds to the content of polar groups contained in 1 g of nanoparticles P, and is multiplied by 10 -3 This is a unit corresponding to mol.
[0061] <Method for Producing Nanoparticle Composition> The method for purifying nanoparticles of the present invention will be described in detail below.
[0062] The purification method of the present invention comprises the following steps: a step of preparing nanoparticles (A) that contain a perovskite-type crystal structure as an allotrope and exhibit multiple crystal structures, a step of preparing a ligand liquid (B) containing a solvent that exhibits a relative dielectric constant of a predetermined value or less and an associative ligand that has a main chain containing multiple carbon atoms and a polar group that is more polar than the main chain and that self-associates in the solvent, and a step of contacting the nanoparticles P with the ligand liquid Q to prepare a nanoparticle dispersion (C).The step of preparing nanoparticle dispersion R also comprises a step of converting the crystal structure of the nanoparticles into a single phase.
[0063] (Step of Preparing Nanoparticles P) The method for preparing nanoparticles P is as described above. If necessary, excess ligands may be removed by centrifugation or the like.
[0064] (Step of Preparing Ligand Liquid Q) To prepare the ligand liquid Q, the second ligand produced by the method described above is dispersed in the second solvent 80. If necessary, the dispersion can be promoted by ultrasonic treatment, heat treatment, or the like.
[0065] (Step of Preparing Nanoparticle Dispersion Liquid R) To prepare the nanoparticle dispersion liquid R, nanoparticles P and ligand liquid Q may be mixed. In this case, the ligand liquid Q may be mixed with solid-phase nanoparticles P, or a dispersion liquid in which nanoparticles P are dispersed in a solvent may be mixed with the ligand liquid Q. The dispersion solvent for nanoparticles P may be the same as or different from the solvent for ligand liquid Q. Furthermore, it is preferable that the dispersion solvent for nanoparticles P exhibits a relative dielectric constant of a predetermined value or less. The predetermined value is preferably 6.0 or less, and more preferably 4.5 or less.
[0066] (Step of Selectively Increasing the Ratio of the Content of a Predetermined Crystal Structure Among the Multiple Crystal Structures) In this embodiment, the step of selectively increasing the ratio of the content of a predetermined crystal structure among the multiple crystal structures preferably includes a step of converting the crystalline structure of the nanoparticles into a single phase. Furthermore, the step of selectively increasing the ratio of the content of a predetermined crystal structure among the multiple crystal structures preferably includes a step of selectively increasing the ratio of the content of a predetermined crystal structure among the multiple crystal structures. As shown in FIG. 1B , the nanoparticle purification method 1000 includes a crystal structure confirmation method 2000 including steps S201 to S209. By performing steps S201 to S209, it is possible to confirm the change in the crystalline structure of the nanoparticles P due to the step of adjusting the nanoparticle dispersion R.
[0067] (First Obtaining Step S203) The first obtaining step S203 includes a step of collecting a first solid content from the nanoparticles P obtained in step S103 and obtaining information about the crystal structure of the first solid content. The information about the crystal structure of the first solid content can be obtained by analytical methods such as a diffraction angle spectrum by X-ray diffraction or a halo pattern obtained by electron beam diffraction.
[0068] (Second Acquisition Step S205) The second acquisition step S205 includes a step of collecting a second solid content from the nanoparticle dispersion and acquiring information about the crystal structure of the second solid content. The method of acquiring the information about the crystal structure of the second solid content is similar to the method of acquiring the information about the crystal structure of the first solid content, but it is preferable that the method of acquiring the information about the crystal structure of the second solid content is the same as the method of acquiring the information about the crystal structure of the first solid content.
[0069] (Step S207 for confirming changes in crystal structure) Step S207 for confirming changes in crystal structure confirms changes in the crystal structure of the nanoparticles P due to the step of adjusting the nanoparticle dispersion liquid based on information regarding the crystal structure of the first solid content and information regarding the crystal structure of the second solid content.
[0070] (Multiple Crystal Structures) Next, the multiple crystal structures exhibited by the nanoparticles P prepared in step S103 will be described.
[0071] The multiple crystal structures include at least one of an α phase, a β phase, and a γ phase, and the predetermined crystal structure preferably includes the α phase. Here, the α phase is a crystal phase classified as a cubic crystal system. The β phase is a crystal phase classified as a tetragonal crystal system. The γ phase is a crystal phase classified as an orthorhombic crystal system. Furthermore, among the α phase, β phase, and γ phase, the α phase is the high-temperature stable phase.
[0072] The plurality of crystal structures preferably includes a plurality of crystal structures synthesized at different temperatures, and the predetermined crystal structure preferably corresponds to the crystal structure synthesized at the highest temperature among the plurality of crystal structures.
[0073] Several crystal structures are also known. 2 X 5 , A 4 BX 6 The crystal structure may be the same as above.
[0074] In the step of converting the crystalline structure of the nanoparticles into a single phase, it is preferable to confirm the single-phase crystalline structure of the nanoparticles by performing X-ray diffraction (XRD) measurement on each of the first solid content in which the nanoparticles P are deposited on a substrate and the second solid content in which the nanoparticle dispersion R is deposited on a substrate. Specifically, the single-phase crystalline structure can be confirmed by the signal observed as a double peak or a broad signal with overlapping peaks in the β phase and γ phase becoming a single peak or becoming sharp.
[0075] The effect of the step of selectively increasing the content ratio of a predetermined crystal structure among a plurality of crystal structures can be confirmed by steps S203 and S205 shown in FIG. 1B.
[0076] The first obtaining step S203 includes a step of collecting a first solid content from a portion of the nanoparticles P and obtaining information about the crystal structure of the first solid content. The second obtaining step S205 includes a step of collecting a second solid content from a portion of the nanoparticle dispersion R and obtaining information about the crystal structure of the second solid content.
[0077] Based on the information regarding the crystalline structure of the first solid content and the information regarding the crystalline structure of the second solid content, a confirmation step S207 confirms that the step of adjusting the mixed liquid R selectively increases the ratio of the content of a specified crystalline structure among multiple crystalline structures.
[0078] In order to promote the formation of a single-phase crystal structure, it is preferable to perform heating, ultrasonic treatment, etc. The heating temperature is preferably 30°C to 100°C, and more preferably 40°C to 80°C.
[0079] (Method for Producing Polymer Compound) A detailed description is given below of a method for producing a polymer compound that can be used as the associating ligand 60. The method for producing the polymer compound is not particularly limited as long as it can produce the polymer compound with the above structure, but the polymer compound can be produced, for example, by the following method (i) or (ii).
[0080] That is, the method (i) for producing a polymer compound includes a method of producing a monomer having a structural unit containing a polar group and then polymerizing the monomer, and the method (ii) for producing a polymer compound includes a method of synthesizing a polymer main chain and then bonding a polar group to the polymer main chain.
[0081] From the viewpoints of easy availability of monomers and control of the amount of functional groups, the method shown in (i) is preferred. Hereinafter, a method for synthesizing a polymer compound containing a zwitterionic group as a polar group using the method shown in (i) will be described in detail.
[0082] As a monomer for introducing a polar group into a polymer compound, a vinyl ether derivative, an acrylate derivative, a methacrylate derivative, an α-olefin derivative, an aromatic vinyl derivative, etc. From the viewpoint of ease of production of the monomer, it is preferable to use an acrylate derivative or a methacrylate derivative as such a monomer.
[0083] The corresponding acrylate or methacrylate derivatives can be produced by the method described in the following literature: K. Ishihara and two others, "Polymer Journal," (Japan), Society of Polymer Science, 1990, Vol. 22, pp. 355-360.
[0084] The method for polymerizing the above monomers includes radical polymerization and ionic polymerization, and living polymerization can also be used for the purpose of controlling the molecular weight distribution and structure. From an industrial perspective, radical polymerization is preferably used.
[0085] Radical polymerization can be carried out by using a radical polymerization initiator, by irradiating with light such as radiation or laser light, by using a photopolymerization initiator in combination with light irradiation, by heating, etc. The radical polymerization initiator may be any one that can generate radicals and initiate a polymerization reaction, and is selected from compounds that generate radicals by the action of heat, light, radiation, an oxidation-reduction reaction, etc.
[0086] For example, azo compounds, organic peroxides, inorganic peroxides, organometallic compounds, photopolymerization initiators, etc. may be mentioned.
[0087] More specific examples include azo compounds such as 2,2'-azobisisobutyronitrile (AIBN) and 2,2'-azobis(2,4-dimethylvaleronitrile); organic peroxides such as benzoyl peroxide (BPO), tert-butyl peroxypivalate, and tert-butylperoxyisopropyl carbonate; inorganic peroxides such as potassium persulfate and ammonium persulfate; and redox initiators such as hydrogen peroxide-iron(II) salt systems, BPO-dimethylaniline systems, and cerium(IV) salt-alcohol systems. Examples of photopolymerization initiators include acetophenone systems, benzoin ether systems, and ketal systems. Two or more of these radical polymerization initiators may be used in combination.
[0088] The preferred temperature range for the polymerization temperature of the vinyl monomer varies depending on the type of polymerization initiator used and is not particularly limited, but polymerization is generally carried out at a temperature of −30° C. to 150° C., and a more preferred temperature range is 40° C. to 120° C.
[0089] The amount of the polymerization initiator used in this case is preferably 0.1 to 20 parts by mass per 100 parts by mass of the monomer, and the amount used is preferably adjusted so as to obtain a polymer compound having the target molecular weight distribution.
[0090] The polymerization method is not particularly limited and may be any of solution polymerization, suspension polymerization, emulsion polymerization, dispersion polymerization, precipitation polymerization, bulk polymerization, and the like.
[0091] The resulting polymer compound may be purified as needed. The purification method is not particularly limited, and methods such as reprecipitation, dialysis, and column chromatography may be used.
[0092] The structure of the produced polymer compound can be identified by various instrumental analyses, such as nuclear magnetic resonance (NMR), gel permeation chromatography (GPC), and inductively coupled plasma atomic emission spectrometry (ICP-AES).
[0093] (Polymerizable Compound) Polymerization of the polymerizable compound is promoted by receiving energy such as light or heat, and the polymerizable compound becomes a component that imparts viscosity to the photoresponsive composition and hardens it. The polymerizable compound can be a radically polymerizable compound or a cationically polymerizable compound. These may be used alone or in combination of two or more. Furthermore, either a photopolymerizable compound or a thermally polymerizable compound can be used. In the present specification, the form in which a polymerizable compound is polymerized and the viscosity is increased may be referred to as a polymer.
[0094] Examples of the radical polymerizable compound that can be used include monofunctional (meth)acrylate compounds, bifunctional (meth)acrylate compounds, trifunctional or higher functional (meth)acrylate compounds, hydroxyl group-containing (meth)acrylate compounds, carboxy group-containing (meth)acrylate compounds, and vinyl compounds.
[0095] Examples of monofunctional (meth)acrylates include methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, isopropyl (meth)acrylate, butyl (meth)acrylate, hexyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, cyclohexyl (meth)acrylate, dicyclopentenyl (meth)acrylate, dicyclopentenyloxyethyl (meth)acrylate, benzyl (meth)acrylate, and 3,3,5-trimethylcyclohexyl acrylate. , tetrahydrofurfuryl (meth)acrylate, phenoxyethyl (meth)acrylate, methoxyethyl (meth)acrylate, ethyl carbitol (meth)acrylate, isobornyl (meth)acrylate, methoxytriethylene glycol (meth)acrylate, (2-methyl-2-ethyl-1,3-dioxolan-4-yl)methyl (meth)acrylate, (3-ethyloxetan-3-yl)methyl (meth)acrylate, and cyclic trimethylolpropane formal (meth)acrylate can be used.
[0096] Examples of bifunctional (meth)acrylate compounds include 1,4-butanediol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, 1,9-nonanediol di(meth)acrylate, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, tetraethylene glycol di(meth)acrylate, polyethylene glycol 200 di(meth)acrylate, polyethylene glycol 300 di(meth)acrylate, polyethylene glycol 400 di(meth)acrylate, and polyethylene glycol 600 Di(meth)acrylate, dipropylene glycol di(meth)acrylate, tripropylene glycol di(meth)acrylate, tetrapropylene glycol di(meth)acrylate, polypropylene glycol 400 di(meth)acrylate, polypropylene glycol 700 di(meth)acrylate, neopentyl glycol di(meth)acrylate, neopentyl glycol PO-modified di(meth)acrylate, EO-modified bisphenol A di(meth)acrylate, PO-modified bisphenol A di(meth)acrylate, and hydroxypivalic acid neopentyl glycol di(meth)acrylate can be used.
[0097] Examples of trifunctional or higher functional (meth)acrylate compounds that can be used include trimethylolpropane tri(meth)acrylate, trimethylolpropane EO-modified tri(meth)acrylate, trimethylolpropane PO-modified tri(meth)acrylate, glycerin propoxy tri(meth)acrylate, pentaerythritol tri(meth)acrylate, tris(acryloxyethyl)isocyanurate, and EO-modified pentaerythritol tetraacrylate.
[0098] Examples of vinyl compounds that can be used include vinyl acetate, vinyl benzoate, vinyl pivalate, vinyl butyrate, vinyl methacrylate, and N-vinylpyrrolidone.
[0099] The cationically polymerizable compound may be either a photopolymerizable compound or a thermally polymerizable compound. These may be used alone or in combination of two or more. Typical examples of the cationically polymerizable compound include epoxy compounds, oxacene compounds, and vinyl ether compounds.
[0100] The amount of the polymerizable compound including the radical polymerizable compound and the cationically polymerizable compound used is preferably 1 to 99 parts by mass, more preferably 3 to 90 parts by mass, and even more preferably 5 to 80 parts by mass, relative to the total parts by mass of the photoresponsive composition.
[0101] (Polymerization initiator) In a polymerization reaction, a polymerization initiator and a polymerizable compound are generally used in combination. The polymerization initiator is a compound that generates active species that initiate a polymerization reaction when irradiated with active energy rays or heat, and known polymerization initiators can be used. Examples of the main active species that initiate a polymerization reaction include radical polymerization initiators that generate radicals and cationic polymerization initiators that generate acids, and these may be used in combination. Examples of photoradical polymerization initiators that generate radicals when exposed to active energy rays include diethoxyacetophenone, 2-hydroxy-2-methyl-1-phenylpropan-1-one, benzyl methyl ketal, 4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-propyl)ketone, 1-hydroxycyclohexyl phenyl ketone, 2-methyl-1-[4-(methylthio)phenyl]-2-morpholinopropan-1-one, 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)butane, oligo[2-hydroxy-2-methyl-1-[4-(1-methylvinyl) acetophenones such as 2-hydroxy-1-[4-[4-(2-hydroxy-2-methylpropionyl)benzyl]phenyl]propanone, 2-hydroxy-1-[4-[4-(2-hydroxy-2-methylpropionyl)benzyl]phenyl]-2-methylpropan-1-one; benzoins such as benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, and benzoin isobutyl ether; phosphines such as 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide and bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide; and other phenyl glyoxylic methyl esters.
[0102] Among the photoradical polymerization initiators, acetophenones such as aminoketones, phosphines, and oxime ester compounds are preferred. These can be used alone or in combination depending on the properties desired for the cured product. When a radical polymerization initiator is used, the amount used is preferably 0.01 to 100 parts by mass, and more preferably 0.1 to 50 parts by mass, per 100 parts by mass of the total solid content in the composition.
[0103] (Other Additives) In this embodiment, the light-responsive composition may be mixed with an oxygen remover, an antioxidant, a scattering agent such as titanium oxide, a surfactant, an anti-mold agent, a light stabilizer, or other additives that impart various properties, a dilution solvent, etc., as needed.
[0104] Second Embodiment A nanoparticle composition 100 according to a second embodiment will be described with reference to FIGS. 3A and 3B.
[0105] A nanoparticle composition 100 according to the second embodiment comprises nanoparticles 110 having a perovskite-type crystal structure as an allotrope, and associating ligands 140 having a main chain 120 containing a plurality of carbon atoms and polar groups 130 that are more polar than the main chain. At least a portion of the associating ligands 140 are coordinated to the nanoparticles 110 via the polar groups 130 so as to change the crystal structure of the nanoparticles.
[0106] (Nanoparticles) In this embodiment, the nanoparticles 110 are nanoparticles containing nanocrystals having a perovskite crystal structure as allotropes, with the A site (monovalent cations), the B site (divalent cations), and the X site (monovalent anions including halide anions) as constituent components. Each constituent component can be the same as that of the nanoparticles P shown in the first embodiment.
[0107] (Associating Ligand) In this embodiment, the associating ligand 140 has a main chain 120 containing multiple carbon atoms and a polar group 130 that is more polar than the main chain. The associating ligand 140 is coordinated to the nanoparticle 110 via the polar group 130 so as to change the crystal structure of the nanoparticle 110.
[0108] The associating ligand 140 may be composed of a low molecular weight compound as shown in Fig. 3A, or may be composed of a high molecular weight compound as shown in Fig. 2B, or may contain both a low molecular weight compound and a high molecular weight compound (not shown).
[0109] From the viewpoint of more effectively inducing a change to the α phase, it is preferable that the material is mainly composed of a polymer compound.
[0110] The main chain 120 of the low molecular weight compound may be a linear, branched, or cyclic alkyl group, a linear, branched, or cyclic heteroalkyl group, an aryl group, a heteroaryl group, an aralkyl group, or a heteroaralkyl group, some of which may further have a substituent.
[0111] The polar group 130 is at least one selected from the group consisting of strong acids such as sulfonic acid and phosphonic acid, strong bases such as quaternary ammonium cations, zwitterionic groups such as sulfobetaine, phosphobetaine, and carboxybetaine, and salts or ions thereof.
[0112] As the polymer compound, a copolymer obtained by polymerizing at least two types of monomers can be used.
[0113] Third Embodiment A nanoparticle composition according to a second embodiment will be described with reference to FIGS. 4A and 4B.
[0114] The nanoparticle composition according to the third embodiment comprises a solvent (201) exhibiting a relative dielectric constant equal to or less than a predetermined value, nanoparticles (210) having a perovskite crystal structure as an allotrope, and a plurality of ligands (240) each having a main chain (220) containing a plurality of carbons and a polar group (230) having more polarity than the main chain, wherein the plurality of ligands (240) comprise a first component (250) that forms a reverse micelle-like structure in the solvent (201) and a second component (260) that coordinates to the particle surface of the nanoparticle.
[0115] The plurality of ligands 240 may be composed of low molecular weight compounds as shown in Fig. 4A, or may be composed of high molecular weight compounds as shown in Fig. 4B, or may contain both low molecular weight compounds and high molecular weight compounds (not shown).
[0116] From the viewpoint of more effectively inducing a change to the α phase, it is preferable that the material is mainly composed of a polymer compound.
[0117] The main chain 210 of the low molecular weight compound may be a linear, branched, or cyclic alkyl group, a linear, branched, or cyclic heteroalkyl group, an aryl group, a heteroaryl group, an aralkyl group, or a heteroaralkyl group, some of which may further have a substituent.
[0118] The polar group 230 is at least one selected from the group consisting of strong acids such as sulfonic acid and phosphonic acid, strong bases such as quaternary ammonium cations, zwitterionic groups such as sulfobetaine, phosphobetaine, and carboxybetaine, and salts or ions thereof.
[0119] As the polymer compound, a copolymer obtained by polymerizing at least two types of monomers can be used.
[0120] (Reverse Micelle-Like Structure) In this embodiment, the reverse micelle-like structure is a structure formed by at least some of the polar groups 230 associating with each other through electrostatic interaction in a solvent 201 exhibiting a relative dielectric constant of a predetermined value or less. The polar groups 230 do not necessarily have to interact directly with each other, and a small amount of polar substance such as water may be present between them. The association may be an intermolecular association or an intramolecular association. Different types of polar groups may also be associated with each other through electrostatic interaction.
[0121] <Fourth embodiment> The flowable nanoparticle compositions 100, 200 exhibit the effect of maintaining the α-phase of the present invention even when cured on a substrate. The nanoparticle composition 200 (100) is in the form of a layer supported on another member, and may therefore be referred to as a wavelength conversion layer. Support forms include a laminated form and a dispersed form in a matrix material. Examples of wavelength conversion layers include those in which the nanoparticle composition is coated on a support member (substrate) and cured to form a film, sheet, or patterned pixels.
[0122] FIG. 5 shows a cross-sectional structure of a display element 400 according to the fourth embodiment.
[0123] The display element 400 has a light-emitting layer 410, a dielectric multilayer film 417, and a wavelength conversion layer 420 stacked in a stacking direction D1. The downstream side in the stacking direction D1 corresponds to the side where a user who views an image drawn on the display element is positioned. The wavelength conversion layer 420 is separated from the wavelength conversion layer corresponding to an adjacent element by a black matrix BM that separates the pixels.
[0124] As described above, nanoparticle composition 200 is employed in a form containing a polymerizable monomer (not shown). Nanoparticle composition 200 containing the polymerizable monomer is cured together with the polymerizable compound by a polymerization treatment such as photopolymerization. Nanoparticle composition 200 is cured to become solid nanoparticle composition 426 supported by dielectric multilayer film 417. Nanoparticle composition 426 is configured to satisfy predetermined dimensions and thereby forms wavelength conversion layer 420 of display element 400. In other words, wavelength conversion layer 420 is a layer solidified by curing the entire nanoparticle composition 200 together with polymerizable compound 150.
[0125] The light-emitting layer 410 corresponds to a light source that emits light L1 of a first wavelength λ1. The wavelength-converting layer 420 has an optical coupling surface 422 that is optically coupled to the light-emitting layer 410 on the light-emitting layer 410 side, and an extraction surface 424 that is converted by the wavelength-converting layer 420 and extracts the secondary light L2 on the opposite side of the light-emitting layer 410.
[0126] The wavelength conversion layer 420 of this embodiment receives primary light L1 of wavelength λ1 propagating through the dielectric multilayer film 417. The dielectric multilayer film 417 provides the display element 400 with the spectral transmission characteristics of the primary light from the light emitting layer 410 and the spectral reflection characteristics of secondary light L2 of wavelength λ2 emitted in the wavelength conversion layer 420. The wavelength λ2 of the secondary light L2 is longer than the wavelength λ1 of the primary light L1.
[0127] The dielectric multilayer film 417 can be replaced with another optical member that is optically transparent to the first wavelength λ1 emitted by the light-emitting layer 410. Furthermore, another optical member (not shown) can be disposed in front of the extraction surface 424 (on the opposite side to the light-emitting layer 410).
[0128] (Method for forming wavelength conversion layer) The method for forming the wavelength conversion layer 420 is not particularly limited, and examples thereof include a method in which a nanoparticle composition is applied to a substrate, followed by pre-drying as necessary, and then, as necessary, by heat treatment or irradiation with active energy rays to harden the film. The thickness of the hardened wavelength conversion layer 420 is preferably 0.1 to 200 μm, more preferably 1 to 100 μm.
[0129] The active energy rays in the active energy ray irradiation are appropriately selected from electromagnetic waves such as heat rays, ultraviolet rays, visible light, near-infrared rays, and electron beams that reduce fluidity and promote curing through polymerization, crosslinking, drying, etc. A light source having a dominant wavelength of emission in the wavelength range of 100 to 450 nm is preferred as the light source for applying the active energy rays. Examples of such light sources include ultra-high pressure mercury lamps, high pressure mercury lamps, medium pressure mercury lamps, mercury xenon lamps, metal halide lamps, high-power metal halide lamps, xenon lamps, pulsed xenon lamps, deuterium lamps, fluorescent lamps, ND-YAG triple harmonic lasers, HE-CD lasers, nitrogen lasers, XE-Cl excimer lasers, XE-F excimer lasers, semiconductor-pumped solid-state lasers, and LED lamp light sources having emission wavelengths of 365 nm, 375 nm, 385 nm, 395 nm, and 405 nm.
[0130] ((Measurement Method)) Various physical properties can be measured as follows.
[0131] ((Molecular Weight Distribution Measurement)) The molecular weight distribution of a polymer compound can be calculated by gel permeation chromatography (GPC) in terms of monodisperse polymethyl methacrylate. Measurement of the molecular weight by GPC can be performed, for example, as follows.
[0132] The sample is added to the eluent below so that the sample concentration becomes 1% by mass, and the solution is left to stand at room temperature for 24 hours to dissolve. The solution is then filtered through a solvent-resistant membrane filter with a pore size of 0.45 μm to obtain the sample solution, which is measured under the following conditions: Apparatus: Agilent 1260 infinity system (Agilent Technologies) Column: PFG analytical linear M columns (PSS) Eluent: 2,2,2-trifluoroethanol Flow rate: 0.2 ml / min Oven temperature: 40°C Sample injection volume: 20 μL
[0133] The molecular weight distribution of the sample is calculated using a molecular weight calibration curve prepared using a standard polymethyl methacrylate resin (EasiVial PM Polymer Standard Kit, manufactured by Agilent Technologies).
[0134] (Structural Analysis of Associating Ligands) Structural analysis of associating ligands can be carried out using nuclear magnetic resonance (NMR). For example, 1H-NMR and 13C-NMR spectrum measurements are carried out using an ECA-600 (600 MHz) manufactured by JEOL Ltd. The measurements are carried out at 25°C in a deuterated solvent containing tetramethylsilane as an internal standard. The chemical shift values are read as ppm shift values (δ values) with tetramethylsilane, the internal standard, set to 0.
[0135] (Method for Confirming That Associative Ligands are Coordinated to Nanoparticles) Whether or not the associative ligands 60 are coordinated to the nanoparticles P can be confirmed by using nuclear magnetic resonance (NMR). For example, using an ECA-600 (600 MHz) manufactured by JEOL Ltd., 1 H-NMR measurement is carried out. 1 Coordination can be confirmed by the fact that the δ value of the H signal shifts from the δ value in the case of the associative ligand alone and the half-value width changes.
[0136] (Analysis of the Association State of Associative Ligands) The association state of associative ligands can be analyzed using NMR or dynamic light scattering (DLS). When NMR is used, for example, an ECA-600 (600 MHz) manufactured by JEOL Ltd. is used to measure 1H-NMR. When association occurs, the chemical shift value of the polar group signal changes from the value in the non-associated state. Furthermore, when association occurs, molecular motion is restricted, and the observed spectrum is broadened overall. If necessary, relaxation time measurement can be performed to analyze the association state in more detail. When DLS is used, the association state can be analyzed from the particle size. When associative ligands form large structures due to intermolecular association, particle diameters of about several hundred nanometers are observed. When intramolecular association occurs, particle diameters of about several nanometers are observed.
[0137] (Crystalline Structure (Crystalline Phase) Analysis of Nanoparticles) Analysis of the crystalline structure (crystalline phase) and composition of nanoparticles can be performed using X-ray diffraction (XRD). For example, the crystalline structure and composition can be analyzed by measuring an X-ray diffraction pattern using a RINT 2100 (manufactured by Rigaku) and comparing it with diffraction patterns in a database. Depending on the shape and size of the specimen to be analyzed, electron diffraction (ED) attached to a cross-sectional TEM may be employed.
[0138] (Method for confirming that the nanoparticles have been converted to a single phase) The fact that the crystalline structure (crystalline phase) of the nanoparticles has been converted to a single phase can be confirmed from a change in the XRD signal. For example, nanoparticles exhibiting the γ phase have a large half-width due to the overlap of two signals at a diffraction angle (2θ) of around 30°, but when they change to the α phase, the half-width becomes smaller.
[0139] ((Nanoparticle Composition Analysis)) The composition of nanoparticles can also be analyzed using XPS and ICP optical emission spectroscopy. The molar ratio of A and B can be measured from the signal intensity of XPS, and the concentration of X can be measured from the emission intensity of ICP optical emission spectroscopy (for example, CIROS CCD (manufactured by SPECTRO)).
[0140] ((Amount of Ligand and Associating Ligand Relative to Nanoparticle P)) The amount of ligand relative to the amount of nanoparticle P can be determined by TG-DTA measurement and NMR measurement. For example, the amount of nanoparticle P in the nanoparticle composition is measured by TG-DTA measurement. Next, the amount of ligand and the amount of associating ligand in the nanoparticle composition are determined by NMR measurement, and the amounts of ligand and associating ligand relative to nanoparticle P can be determined.
[0141] ((Amount of Polar Groups in Associating Ligand)) The amount of polar groups in the associating ligand can be determined by NMR measurement. For example, 1H-NMR is measured using an ECA-600 (600 MHz) manufactured by JEOL Ltd. The amount of polar groups in the associating ligand is calculated by comparing the signal intensity derived from the polar groups with the signal intensity derived from other parts.
[0142] ((Number of mmoles of polar groups per 1 g of nanoparticles)) The number of mmoles of polar groups per 1 g of nanoparticles can be calculated from the amount of nanoparticles P determined by the above method, the amount of associating ligands, and the amount of polar groups in the associating ligands.
[0143] The present disclosure will be described in more detail below with reference to examples, but the present disclosure is not limited to these examples.
[0144] [Production of Associating Ligand a] A reaction vessel equipped with a condenser, stirrer, thermometer, and nitrogen inlet tube was prepared. 0.8 parts of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid, 51.1 parts of hexyl methacrylate, 3.9 parts of azobisisobutyronitrile, and 900 parts of 2,2,2-trifluoroethanol were charged into the reaction vessel. Nitrogen bubbling was then performed on the reaction vessel for 30 minutes. The resulting reaction mixture was heated at 65°C for 8 hours under a nitrogen atmosphere to complete the polymerization reaction. After cooling the reaction solution to room temperature, 300 parts of water was added to precipitate the product. After centrifugation, the supernatant was removed. The solvent was removed by distillation under reduced pressure, followed by drying under reduced pressure at 50°C and 0.1 kPa or less to obtain Associating Ligand a. NMR analysis confirmed that the structural unit having a polar group accounted for 1 mol% of all monomer units. Furthermore, GPC analysis revealed that the weight average molecular weight (Mw) was 12,500.
[0145] [Production of Associating Ligand b] Associating ligand b was produced in the same manner as in the production of associating ligand a, except that the amount of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed from 0.8 parts to 5.9 parts and the amount of hexyl methacrylate was changed from 51.1 parts to 48.0 parts.
[0146] [Production of Associating Ligand c] Associating ligand c was produced in the same manner as in the production of associating ligand a, except that the amount of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed from 0.8 parts to 6.8 parts and the amount of hexyl methacrylate was changed from 51.1 parts to 47.5 parts.
[0147] [Preparation of Associating Ligand d] Associating ligand d was prepared in the same manner as for preparing associating ligand a, except that the amount of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed from 0.8 parts to 10.2 parts and the amount of hexyl methacrylate was changed from 51.1 parts to 45.4 parts.
[0148] [Preparation of Associating Ligand e] Associating ligand e was prepared in the same manner as for preparing associating ligand a, except that the amount of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed from 0.8 parts to 15.2 parts and the amount of hexyl methacrylate was changed from 51.1 parts to 42.3 parts.
[0149] [Preparation of Associating Ligand f] Associating ligand f was prepared in the same manner as in the preparation of associating ligand a, except that the amount of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed from 0.8 parts to 20.3 parts and the amount of hexyl methacrylate was changed from 51.1 parts to 39.2 parts.
[0150] [Preparation of Associating Ligand g] Associating ligand g was prepared in the same manner as in the preparation of associating ligand a, except that the amount of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed from 0.8 parts to 33.9 parts and the amount of hexyl methacrylate was changed from 51.1 parts to 31.0 parts.
[0151] [Preparation of Associating Ligand h] Associating ligand h was prepared in the same manner as in the preparation of associating ligand a, except that in the preparation of associating ligand a, 0.8 parts of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was replaced with 10.7 parts of 2-(methacryloyloxy)ethyl 2-(trimethylammonio)ethyl phosphate, and the amount of hexyl methacrylate was changed from 51.1 parts to 45.4 parts.
[0152] [Preparation of Associating Ligand i] Associating ligand i was prepared in the same manner as for preparing associating ligand a, except that in the preparation of associating ligand a, 0.8 parts of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed to 7.8 parts of 2-[[2-(methacryloyloxy)ethyl]dimethylammonio]acetic acid, and the amount of hexyl methacrylate was changed from 51.1 parts to 45.4 parts.
[0153] [Preparation of Associating Ligand j] 7.6 parts of [2-(methacryloyloxy)ethyl]trimethylammonium chloride (80% aqueous solution), 45.4 parts of hexyl methacrylate, 3.9 parts of azobisisobutyronitrile, and 900 parts of n-butanol were charged into a reaction vessel equipped with a condenser, stirrer, thermometer, and nitrogen inlet tube, and nitrogen bubbling was performed for 30 minutes. The resulting reaction mixture was heated at 65°C for 8 hours under a nitrogen atmosphere to complete the polymerization reaction. After cooling the reaction solution to room temperature, 300 parts of water was added to precipitate the product. After centrifugation, the supernatant was removed. The solvent was distilled off under reduced pressure, and the mixture was dried under reduced pressure at 50°C and 0.1 kPa or less. 5 parts of the resulting solid was dissolved in 95 parts of tetrahydrofuran, to which a solution of 1.3 parts of sodium bromide in 2.7 parts of water was slowly added, and the mixture was stirred at room temperature for 2 hours. The resulting solution was reprecipitated with water, washed with methanol, and then vacuum dried at 50° C. for 6 hours to produce associative ligand j.
[0154] [Production of Associating Ligand K] Associating ligand k was produced in the same manner as in the production of associating ligand a, except that in the production of associating ligand a, 0.8 parts of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed to 3.1 parts of methacrylic acid and the amount of hexyl methacrylate was changed from 51.1 parts to 45.4 parts.
[0155] [Preparation of Associating Ligand 1] As associating ligand 1, octadecyldimethyl(3-sulfopropyl)ammonium hydroxide inner salt (manufactured by Tokyo Chemical Industry Co., Ltd.) was prepared.
[0156] The structures, compositions and molecular weights of the associative ligands a to k that were produced and prepared are shown in Table 1.
[0157]
[0158] [Preparation of association liquid] (Association liquid of associating ligand a in toluene) 1 part of associating ligand a and 99 parts of toluene were placed in a reaction vessel equipped with a stirrer, a thermometer, and a reflux condenser, and the temperature was raised to 110°C and heated for 5 minutes. After confirming that associating ligand d had completely dissolved, the mixture was cooled to room temperature to obtain association liquid a of associating ligand a in toluene.
[0159] (Association Solutions of Associating Ligands b to l in Toluene) Association solutions b to l of polymer compounds b to l in toluene were prepared in the same manner as for the association solution of associating ligand a in toluene, except that associating ligands b to l were used instead of associating ligand a.
[0160] (Associated Liquid of Associating Ligand d in Hexane) 1 part of associating ligand d and 99 parts of hexane were placed in a reaction vessel equipped with a stirrer, a thermometer, and a reflux condenser, and the temperature was raised to 60°C and heated for 5 minutes. After cooling to room temperature, an associated liquid of associating ligand d in hexane d-2 was obtained.
[0161] (Association Solution of Associating Ligand d in Chloroform) 1 part of associating ligand d and 99 parts of chloroform were placed in a reaction vessel equipped with a stirrer, a thermometer, and a reflux condenser, and the temperature was raised to 60°C and heated for 5 minutes. After cooling to room temperature, an association solution d-3 of associating ligand d in chloroform was obtained.
[0162] (Associated Liquid of Associating Ligand d in Ethyl Acetate) 1 part of associating ligand d and 99 parts of ethyl acetate were placed in a reaction vessel equipped with a stirrer, a thermometer, and a reflux condenser, and the temperature was raised to 70°C and heated for 5 minutes. After cooling to room temperature, associated liquid d-4 of associating ligand d in ethyl acetate was obtained.
[0163] [Production of Nanoparticles P-1] 10 parts of cesium carbonate, 27 parts of oleic acid, and 385 parts of 1-octadecene were placed in a flask, heated to 120°C, and degassed for 30 minutes using a vacuum pump. The mixture was further heated to 150°C under a dry nitrogen stream and maintained for 30 minutes to obtain a cation raw material solution.
[0164] Separately, 10 parts of lead(II) bromide and 494 parts of 1-octadecene were placed in a flask, heated to a liquid temperature of 120°C, and degassed for 1 hour using a vacuum pump. 89 parts of oleic acid and 31 parts of oleylamine were added, and the mixture was further degassed for 30 minutes using a vacuum pump. Thereafter, the nitrogen flow was replaced and the liquid temperature was raised to 185°C.
[0165] 40 parts of the cation source liquid was added, and after 5 seconds, the mixture was cooled on ice. 2000 parts of ethyl acetate was added, and the mixture was centrifuged to remove the supernatant. The resulting residue was dispersed in toluene to adjust the solid concentration to 1% by weight, and CsPbBr 3A dispersion of nanoparticles P-1 having a perovskite crystal structure was obtained. The ratio of nanoparticles P in the solid content measured by TG-DTA was 53 wt %. XRD measurement revealed that the nanoparticles P were CsPbBr 3 The signal originating from the γ phase of CsPb 2 Br 5 A signal originating from
[0166] [Production of Nanoparticles P-2] CsPb(Br / I) was prepared in the same manner as in the luminescent nanocrystal dispersion a, except that 3.2 parts of lead(II) bromide and 9.3 parts of lead(II) iodide were used instead of 10 parts of lead(II) bromide. 3 A dispersion of nanoparticles P-2 having a perovskite crystal structure was obtained. The ratio of nanoparticles P in the solid content measured by TG-DTA was 52 wt %. XRD measurement revealed that CsPb(Br / I) 3 A signal originating from the γ phase was observed.
[0167] [Production of Nanoparticles P-3] Nanoparticles P-3 were produced in the same manner as nanoparticles P-1, except that the liquid temperature was changed to 220°C. 3 Nanoparticles P-3 having a perovskite crystal structure were produced. The ratio of nanoparticles P in the solid content measured by TG-DTA was 55 wt %. XRD measurement revealed that the nanoparticles were CsPbBr 3 Signals originating from the α and γ phases were observed.
[0168] Example 1 100 parts of dispersion a of nanoparticles P-1 were placed in a container, and the solvent was distilled off under reduced pressure. 100 parts of association solution a of associative ligand a in toluene were added, and ultrasonic treatment was performed for 20 minutes to promote coordination and changes in the crystalline phase, yielding nanoparticle composition 100-1.
[0169] Examples 2 to 16, Comparative Examples 1 to 4 Nanoparticle compositions 100-2 to 20 were obtained in the same manner as in Example 1, except that the types of nanoparticles P, associative ligands, and associative liquid were changed as shown in Table 2.
[0170]
[0171] [Evaluation] [Evaluation of crystalline phase immediately after treatment] Immediately after treatment, 50 μL of each solution was placed in a sample holder to remove the solvent, and XRD measurement was performed. When nanoparticles P-1 were used, the half-width of the signal having a maximum value in the diffraction angle (2θ) range of 30° to 31° was measured, and when nanoparticles P-2 were used, the half-width of the signal having a maximum value in the diffraction angle (2θ) range of 28° to 30° was measured. The evaluation criteria are as follows. <Evaluation criteria> A: Half-width is 0.85° or less B: Half-width is more than 0.85° and 0.9° or less C: Half-width is more than 0.9° and 0.98° or less D: Half-width is greater than 0.98°
[0172] [Evaluation of crystalline phase after aging] The sample holder after evaluation of the crystalline phase immediately after treatment was left stationary in a draft for one week, and then XRD measurement was performed again. When nanoparticles P-1 were used, the half-width of the signal having a maximum value in the diffraction angle (2θ) range of 30° to 31° was measured, and when nanoparticles P-2 were used, the half-width of the signal having a maximum value in the diffraction angle (2θ) range of 28° to 30° was measured. The evaluation criteria are as follows. <Evaluation criteria> A: Half-width is 0.85° or less B: Half-width is more than 0.85° and less than 0.9° C: Half-width is more than 0.9° and less than 0.98° D: Half-width is greater than 0.98°
[0173] The evaluation results are shown in Table 3.
[0174]
[0175] According to Table 3, the nanoparticle compositions 100-1 to 16 according to Examples 1 to 16 have a single-phase crystalline phase immediately after treatment compared to the nanoparticle compositions 100-17 to 19 according to Comparative Examples 1 to 3. Furthermore, the crystalline phase remains single-phase even after aging. These results are thought to be due to the fact that the associative ligand 60 coordinates with the nanoparticles P having a perovskite structure in the low-polarity solvent 10, resulting in a single-phase crystalline phase. Note that the nanoparticle composition 20 containing the nanoparticles P-3 synthesized at high temperature contains an α-phase crystalline phase immediately after treatment, but is unable to maintain the α-phase over time.
[0176] The present invention is not limited to the above-described embodiments, and various modifications and variations can be made without departing from the spirit and scope of the present invention. Therefore, the following claims are appended to apprise the public of the scope of the present invention.
[0177] This application claims priority based on Japanese Patent Application No. 2023-083370, filed on May 19, 2023, the entire contents of which are incorporated herein by reference.
[0178] 1000 Method for producing nanoparticle composition (method for purifying nanoparticles) S103 Step of preparing nanoparticles exhibiting multiple crystal structures S105 Step of preparing a ligand liquid S107 Step of preparing a nanoparticle dispersion S109 Step of selectively increasing the content ratio of a predetermined crystal structure among multiple crystal structures (step of making the crystal structure of the nanoparticles single-phase)
Claims
1. A method for purifying nanoparticles, comprising: preparing nanoparticles that contain a perovskite-type crystal structure as an allotrope and exhibit a plurality of crystal structures; preparing a ligand liquid containing a solvent exhibiting a relative dielectric constant of a predetermined value or less and an associative ligand that has a main chain containing a plurality of carbons and a polar group that is more polar than the main chain and that self-associates in the solvent; and contacting the nanoparticles with the ligand liquid to prepare a nanoparticle dispersion, wherein the step of adjusting the nanoparticle dispersion includes a step of selectively increasing the ratio of the content of a predetermined crystal structure among the plurality of crystal structures.
2. A method for purifying nanoparticles as described in claim 1, wherein the step of selectively increasing the ratio of the content of a specific crystal structure among the multiple crystal structures includes a step of making the crystal structure of the nanoparticles single-phase.
3. A method for purifying nanoparticles as described in claim 1 or 2, wherein the step of selectively increasing the ratio of the content of a specified crystal structure among the multiple crystal structures includes a step of selectively increasing the ratio of the content of a specified crystal structure among the multiple crystal structures.
4. A method for purifying nanoparticles as described in claim 2 or 3, wherein the multiple crystal structures include at least one of the alpha phase, beta phase, and gamma phase, and the specified crystal structure includes the alpha phase.
5. A method for purifying nanoparticles as described in claim 2 or 3, wherein the multiple crystal structures include multiple crystal structures having different synthesis temperatures, and the specified crystal structure corresponds to the crystal structure having the highest synthesis temperature among the multiple crystal structures.
6. A method for purifying nanoparticles as described in claim 1 or 2, comprising: a first acquisition step of collecting a first solid content from the nanoparticles and acquiring information regarding the crystal structure of the first solid content; and a second acquisition step of collecting a second solid content from the nanoparticle dispersion and acquiring information regarding the crystal structure of the second solid content.
7. A method for purifying nanoparticles as described in claim 6, comprising a step of confirming a change in the crystal structure of the nanoparticles due to the step of adjusting the nanoparticle dispersion liquid based on information regarding the crystal structure of the first solid content and information regarding the crystal structure of the second solid content.
8. The method for purifying nanoparticles described in claim 1 or 2, wherein the polar group contains at least one selected from the group consisting of a strong acid, a strong base, a zwitterionic group, and salts or ions thereof.
9. The method for purifying nanoparticles according to claim 1 or 2, wherein the polar group contains at least one selected from the group consisting of sulfonic acid, phosphonic acid, quaternary ammonium cation, sulfobetaine, phosphobetaine, and carboxybetaine.
10. A method for producing a nanoparticle composition, comprising: preparing nanoparticles having a perovskite-type crystal structure as an allotrope and exhibiting a plurality of crystal structures; preparing a ligand liquid comprising a solvent exhibiting a relative dielectric constant of a predetermined value or less and an associative ligand having a main chain containing a plurality of carbons and a polar group more polar than the main chain, and which self-associates in the solvent; and contacting the nanoparticles with the ligand liquid to prepare a nanoparticle dispersion, wherein the step of adjusting the nanoparticle dispersion comprises a step of selectively increasing the ratio of the content of a predetermined crystal structure among the plurality of crystal structures.
11. The method for producing a nanoparticle composition according to claim 10, further comprising the step of adding a polymerizable compound to the nanoparticle dispersion.
12. A nanoparticle composition comprising: nanoparticles having a perovskite-type crystal structure as an allotrope; and associative ligands having a main chain containing a plurality of carbons and a polar group having a polarity greater than that of the main chain, wherein at least a portion of the associative ligands are coordinated to the nanoparticles via the polar group so as to change the crystal structure of the nanoparticles.
13. A nanoparticle composition comprising: a solvent exhibiting a relative dielectric constant equal to or lower than a predetermined value; nanoparticles having a perovskite-type crystal structure as an allotrope; and a plurality of ligands having a main chain containing a plurality of carbons and a polar group more polar than the main chain, wherein the plurality of ligands include a first component that forms a reverse micelle-like structure in the solvent and a second component that coordinates to the particle surface of the nanoparticles.
Citation Information
Patent Citations
Coated metal oxide nanoparticles and method of making same
JP2008544936A
Luminescent material, luminescent material composition, luminescence conversion member, backlight unit, and liquid crystal display device
JP2021091870A
Method for producing light-emitting particles, light-emitting particles, light-emitting particle dispersion, ink composition, and light-emitting element
WO2020235480A1
Nanoparticle film, method for manufacturing nanoparticle film, and display panel
WO2023103054A1
